ArticlePolymers2021
Valorization of Date Palm Waste for Plastic Reinforcement: Macro and Micromechanics of Flexural Strength.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 18 citations in OpenAlex.
- Starch-modified date palm leaf fibers for eco-friendly epoxy biocomposites: microstructural, structural, and thermal characterization.Scientific reports · 2026Article
- Effect of benzoyl chloride treatment on morphological, thermal, mechanical, and hydrothermal aging properties of date palm/polyvinyl chloride (PVC) composites.Scientific reports · 2024Article
- Article
- Optimizing Alternative Substrate for Tomato Production in Arid Zone: Lesson from Growth, Water Relations, Chlorophyll Fluorescence, and Photosynthesis.Plants (Basel, Switzerland) · 2023Article
- Article
- Exploring the Potential of Cotton Industry Byproducts in the Plastic Composite Sector: Macro and Micromechanics Study of the Flexural Modulus.Materials (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Date palm waste is an abundant agricultural residue in Tunisia and can be used for plastic reinforcement. Moreover, its use in plastic composites can help to reduce dependence on fossil resources for material production. In this work, the valorization of date palm residues was studied by employing high-yield processes following mechanical, chemical, and enzymatical treatments. Fibers obtained by soft chemical treatment with sodium hydroxide and enzymatic treatment with xylanases and pectinases were evaluated for their use in the reinforcement of plastic materials. The flexural strength property, truly relevant for structural, construction, automotive, or other market sectors, was adopted to assess the reinforcing potential of the fibers. Polypropylene was effectively reinforced with date palm fibers (60 wt.%), exhibiting a flexural strength increases of 80% (73.1 MPa), 93% (78.5 MPa), and 106% (83.9 MPa) for mechanical, chemical, and enzymatic fibers, respectively. The different treatments had an impact on the chemical composition of the fibers, and by extension on the final properties of the composites. The holocellulose content could provide good interfacial adhesion using a coupling agent, whereas the lignin content improved the dispersion of the phases. Two interesting outcomes were that the flexural performance of enzymatic fibers was like that of wood composites, whereas the specific flexural strength was comparable to that of glass fiber composites. Overall, the present work has shown the potential behind date palm waste in the composite sector when a specific property or application is desired. Novel treatments have been used for greater fiber compatibility, increasing the sustainability of the process, and improving the applicability of the palm residue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.